Reports: Mich. bill would allow marijuana sales in pharmacies
NEW YORK — State legislators in Michigan are considering a bill that would allow pharmacies to sell medical marijuana, according to published reports.
The Detroit Free Press reported that the state Senate Government Operations Committee had passed a bill that would reclassify marijuana as a Schedule 2 controlled substance and allow licensing and regulation of companies to grow and test pharmaceutical-grade marijuana and then sell it to pharmacies to dispense. The newspaper reported, however, that the federal government would first have to reclassify marijuana as well, as it is currently a Schedule 1 controlled substance, meaning the government regards it solely as an illegal drug with no legitimate medical use.
Opponents of the bill say it would take business from small-scale and home growers and was a "money grab" by large growers and pharmacies.
Should pharmacies be allowed to sell medical marijuana as Michigan state lawmakers propose? Click Here to Vote
Reports: Schnucks opens infusion services center in St. Louis
NEW YORK — Schnuck Markets is expanding its presence in specialty pharmacy services, according to published reports.
The St. Louis Post-Dispatch reported that Schnucks opened its first Schnucks Infusion Solutions location last month in St. Louis, where the supermarket chain is based.
The 6,500-sq.-ft. facility provides infusion services for serious, chronic conditions like autoimmune diseases, hemophilia, cancers and others, staffed by nurses, pharmacists and pharmacy technicians who prepare infusions and administer them in patients’ homes or its ambulatory infusion center.
Schnucks has been involved in specialty for a while. In May 2012, it opened a stand-alone pharmacy in the pavilion of St. John’s Hospital in Springfield, Ill., its first stand-alone specialty pharmacy in Illinois. The 2,000-sq.-ft. pharmacy specializes in conditions like HIV, hepatitis, autoimmune disorders, organ transplants and cancers and replaced the specialty pharmacy at a nearby store.
FDA approves generic injectable antibiotic
SILVER SPRING, Md. – The Food and Drug Administration has approved a generic injectable antibiotic drug made by Emcure Pharmaceuticals, according to the agency.
The FDA approved Emcure’s vancomycin hydrochloride injection in the 5-g-per-vial strength.
The drug is a generic version of Vancocin, made by ViroPharma.